Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30,210,911
-
Number of holders
-
165
-
Total 13F shares, excl. options
-
16,260,263
-
Shares change
-
-59,137
-
Total reported value, excl. options
-
$323,227,753
-
Value change
-
+$1,152,439
-
Put/Call ratio
-
13%
-
Number of buys
-
78
-
Number of sells
-
79
-
Price
-
$19.88
Institutional Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q2 2025
As of 30 Jun 2025 Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) had 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,260,263 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, Point72 Asset Management, L.P., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and AMERIPRISE FINANCIAL INC.
This table shows 202 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.